SCHEMBL13340318

SCHEMBL13340318

Cc1ccc(-c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3c4ccccc4c4ccccc4c3c2-c2ccc(N(c3ccccc3)c3ccccc3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.36
MAPT P10636 3/20 0.34
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
ACHE P22303 2/20 0.33
POLB P06746 1/20 0.33
PPARG P37231 1/20 0.33
MCL1 Q07820 1/20 0.33
NR2E3 Q9Y5X4 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CRHR1 P34998 1/20 0.32
HPRT1 P00492 1/20 0.32
ALDH1A1 P00352 4/20 0.32
CYP2C19 P33261 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13340287 1.00 GPR84 (0.36) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13340285 0.99 MAPT (0.36) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13340310 0.97 MAPT (0.37) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13340133 0.95 GPR84 (0.33) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13340015 0.95 GPR84 (0.33) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13340128 0.94 MAPT (0.34) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13340130 0.94 MAPT (0.34) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13339949 0.94 MAPT (0.34) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13339812 0.94 MAPT (0.34) GPR84MAPTKDM4EMEN1KMT2A
SCHEMBL13339968 0.94 MAPT (0.34) GPR84MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 GPR84 994/4885MAPT 3478/4885KDM4E 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.